Alligator Bioscience AB presents at Redeye Life Science Seminar 24 November 2017
Lund, Sweden, 21 November 2017 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, presents the company at Redeye Life Science Seminar on Friday 24 November (10:15 am CET) at Haymarket in Stockholm, Sweden. The presentation can be followed in real-time at www.redeye.se. The presentation will also be accessible after the event at www.redeye.se and on the company page at Redeye Universe (www.redeye.se/company/alligator-bioscience). For further information:Cecilia Hofvander, Director